To read this content please select one of the options below:

Vaccine manufacturer’s role in the global vaccine enterprise

Daniel M. Gordon (DMGordon Consulting, LLC, Nazareth, Pennsylvania, USA)
Corwin A. Robertson (US Scientific and Medical Affairs, Sanofi Pasteur Inc, Swiftwater, Pennsylvania, USA)

International Journal of Health Governance

ISSN: 2059-4631

Article publication date: 4 September 2017

270

Abstract

Purpose

The purpose of this paper is to describe the role of the vaccine manufacturer in the global vaccine enterprise.

Design/methodology/approach

Narrative review.

Findings

Pharmaceutical companies involved in the vaccine enterprise play critical and often unrecognized roles in the global health management arena. In addition to the obvious role of vaccine production and distribution, companies are often involved in the identification of infectious agents for which vaccines may be of benefit, basic and applied research, process development, pre-clinical and clinical evaluations of vaccine candidates, as well as continuous post-licensure safety monitoring efforts. Vaccine manufacturers interact with health and regulatory agencies, academia and agencies interested in supporting cost-effective means of vaccine distribution to areas most in need of life-saving vaccines.

Originality/value

This review provides the reader with an understanding of the many roles of the manufacturer in the global vaccine enterprise.

Keywords

Citation

Gordon, D.M. and Robertson, C.A. (2017), "Vaccine manufacturer’s role in the global vaccine enterprise", International Journal of Health Governance, Vol. 22 No. 3, pp. 161-166. https://doi.org/10.1108/IJHG-03-2017-0012

Publisher

:

Emerald Publishing Limited

Copyright © 2017, Emerald Publishing Limited

Related articles